Peer-reviewed Publications

1. Factors affecting anatomical and visual outcome after macular hole surgery: findings from a large prospective UK cohort Steel DH, Donachie PHJ, Aylward GW, Laidlaw DA, Williamson TH, Yorston D; Jalil A, BEAVRS Macular hole outcome group.
Eye (Lond). 2020 Mar 30. doi: 10.1038/s41433-020-0844-x.

2. How Big is the Hole? Measuring Intra- and Inter-Individual Agreement in Macular Hole Size Measurements
Antonopoulou PG, Baumann C, Jalil A, Dhawahir-Scala F, Muñoz-Sanz N, Lu VHJ, Park D, Patton N.
Curr Eye Res. 2020 Jan 3:1-5.

3. Management of penetrating injury with retained intraocular lead foreign body from a writing instrument: surgical video with implications for paediatric public health and safety
Qureshi A, Kelly SP, Carley F, Jalil A
BMJ Case Rep. 2019 Nov 25;12(11)

4. Spontaneous resolution of submacular Perfluorocarbon liquids (PFCL) Bauman C, Cheng C, Jalil A, Patton N
Retinal Cases & Brief Reports. 2019 Jul 16. doi: 10.1097/ICB.0000000000000899

5. Macular toxicity secondary to occupational exposure to gold melting
Almuhtaseb H, Tsokolas G, Lotery A, Jalil A
Eye (Lond). 2019 May 20. doi: 10.1038/s41433-019-0471-6.

6. The Manchester Large Macular Hole Study: Is it time to reclassify large macular holes?
Ch’ng S, Patton N, Ahmed M, Ivanova T, Bauman C, Charles S, Jalil A
Am J Ophthalmol. 2018;195:36-42. doi: 10.1016/j.ajo.2018.07.027.

7. The Effect of Bevacizumab Before Vitrectomy for Diabetic Tractional Retinal Detachment demonstrated on Optical Coherence Tomography Angiography
Ch’ng S, Papayannis A, Stringa F, Stanga P E, Tsamis E, Jalil A
J Curr Ophthalmol. 2018; 21;30(3):276-279. doi: 10.1016/j.joco.2018.06.001

8. Electronic retinal implants and artificial vision: journey and present
Mills JO, Jalil A, Stanga PE
Eye (Lond). 2017 May 26. doi: 10.1038/eye.2017.65

9. Segmented swept source OCTA assessment of the perifoveal vasculature in patients with X-linked juvenile retinoschisis: a serial case report
Stringa F, Tsamis E, Papayannis A, Chwiejczak K, Jalil A, Biswas S, Ahmad H, Stanga PE
Int Med Case Rep J. 2017;10: 329-335

10. Antiplatelets and Anticoagulants in vitreoretinal surgery with a special emphasis on Novel Anticoagulants – A national survey and review
Patel R, Charles S, Jalil A
Graefes Arch Clin Exp Ophthalmol. 2017 Apr 18. doi:

11. Vitrectomy for Primary Symptomatic Vitreous Opacities: an evidence-based review
Ivanova T, Jalil A, Antoniou Y, Bishop PN, Vallejo-Garcia JL, Patton N
Eye (Lond). 2016 May;30(5):645-55.

12. A unique case of eyeball tattooing leading to ocular penetration and intraocular tattoo pigment deposition
Jalil A, Ivanova T, Bonshek R, Patton N
Clin Experiment Ophthalmol. 2015 Feb 5. doi: 10.1111/ceo.1250

13. A case of Hunter syndrome with bilateral retinal detachment
Ivanova T, Jalil A, Vallejo-Garcia JL, Patton N
Eye (Lond). 2014 Sep 5. doi: 10.1038/eye.2014.202.

14. Microincision Cataract Surgery (MICS) combined with Vitrectomy: a case series
Jalil A, Steeples L, Subraamni S, Bindra MS, Dhawahir-Scala F, Patton N
Eye (Lond). 2014 Apr;28(4):386-9

15. Bilateral paediatric optic neuropathy precipitated by vitamin B12 deficiency and a novel mitochondrial DNA mutation
Jalil A, Usmani HA, Khan I, Blakely E, Taylor RW, Vassallo G, Ashworth J
International Ophthalmology. 2013:33(6):687-690

16. Iatrogenic retinal breaks in 20-G versus 23-G Pars Plana Vitrectomy
Jalil A, Ho W, Charles S, Dhawahir-Scala FE, Patton N
Graefes Arch Clin Exp Ophthalmol. 2013;251(6):1463-7.

17. Vision-related quality of life and employment status in patients with uveitis of working age: a prospective study
Jalil A, Yin K, Coyle L, Harper R, Jones NP
Ocul Immunol Inflamm. 2012;20(4):262-5

18. Treatment of dry eye: An analysis of the British Sjögren’s Syndrome Association comparing substitute tear viscosity and subjective efficacy
Bhojwani R, Cellesi F, Maino A, Jalil A, Haider D, Noble B
Cont Lens Anterior Eye. 2011;34(6):269-73

19. Wrong intraocular lens implant: learning from reported patient safety incidents
Kelly SP, Jalil A
Eye (Lond). 2011;25(6):730-4

20. Combined trabeculotomy-trabeculectomy combined with 5-fluorouracil in paediatric glaucoma
Jalil A, Au L, Khan I, Ashworth J, Lloyd IC, Biswas S
Clin Experiment Ophthalmol. 2011;39(3):207-14

21. Compressed air injury causing pneumo-orbit and xanthopsia
Khan I, Clark L, Jalil A, Ataullah S
Injury Extra. 2011;42:11–12

22. Clinical review of periorbital capillary hemangioma of infancy
Jalil A, Maino A, Bhojwani R, Vose M, Ashworth J, Lloyd IC, Biswas S
J Pediatr Ophthalmol Strabismus. 2010;28:1-8

23. Exudative retinal detachment following photodynamic therapy for retinal capillary hemangioma
Wong YM, Jalil A, Mathews J, Stanga PE
Can J Ophthalmol. 2010;45(3):1-2

24. Drainage of subretinal fluid in optic disc pit maculopathy using subretinal 42-gauge cannula: a new surgical approach
Jalil A, Stavrakas P, Dhawahir-Scala FE, Patton N
Graefes Arch Clin Exp Ophthalmol. 2010;248(5):751-3.

25. Non-progressive tractional inferior retinal elevation in intermediate uveitis
Jalil A, Dhawahir-Scala FE, Jones NP
Ocul Immunol Inflamm. 2010;18(1):60-3

26. Choroidal non-perfusion with significant subretinal exudation after PDT of predominantly classic CNV: an OCT and FFA study
Jalil A, Mercieca K, Chaudhry NL, Stanga PE
Eur J Ophthalmol. 2009;19(3):490-3

27. Non-Hodgkin’s lymphoma presenting with proptosis in an infant
Sanghvi C, Mercieca K, Jalil A, Lloyd IC
J AAPOS. 2008;12(5):514-5

28. Intravitreal bevacizumab (Avastin) causing acute glaucoma: an unreported complication
Jalil A, Fenerty C, Charles S
Eye (Lond). 2007;21(12):1541

29. Retinal Pigment Epithelial Tear Following Intravitreal Injection of Bevacizumab (Avastin®): Optical Coherence Tomography and Fluorescein Angiographic Findings
Mathews J. P, Jalil A, Lavin, MJ, Stanga PE
Eye (Lond). 2007;21(7):1004-5

30. Inadvertent Injection of Triamcinolone into the Crystalline Lens
Jalil A, Chaudhry NL, Mustafa T, Gandhi J, Yodaiken M
Eye (Lond). 2007;21(1):152-4

Book Chapters

1.Swept-Source Optical Coherence Tomography AngioTM (Topcon Corp, Japan): Technology Review
Stanga PE, Tsamis E, Papayannis A, Stringa F, Cole T, Jalil A
Bandello F, Souied EH, Querques G (eds): OCT Angiography in Retinal and Macular Diseases. Dev Ophthalmol. Basel, Karger. 2016;56:13-7.

2.New Findings in Diabetic Maculopathy and Proliferative Disease by Swept-Source Optical Coherence Tomography Angiography
Stanga PE, Papayannis A, Tsamis E, Stringa F, Cole T, D’Souza Y Jalil A
Bandello F, Souied EH, Querques G (eds): OCT Angiography in Retinal and Macular Diseases. Dev Ophthalmol. Basel, Karger. 2016;56:113-21.

3.Swept-Source Optical Coherence Tomography Angiography of Paediatric Macular Diseases
Stanga P E, Papayannis A, Tsamis E, Chwiejczak K, Stringa F, Jalil A, Cole T, Biswas S
Bandello F, Souied EH, Querques G (eds): OCT Angiography in Retinal and Macular Diseases. Dev Ophthalmol. Basel, Karger. 2016;56:166-73.

About me

Mr. Assad Jalil is a Consultant Ophthalmologist, Vitreoretinal and
Cataract Surgeon and Uveitis Specialist.

He is the Lead Clinician of Vitreoretinal Surgery at Manchester Royal Eye
Hospital, one of the leading ophthalmic units of Europe, and a centre for
clinical and research excellence.

He is also the UK Professional Standards Lead for British and Eire
Association of Vitreoretinal Surgeons (BEAVRS).

Mr. Jalil has extensive experience in all aspects of latest vitreoretinal
surgery including 23G, 25G and 27G pars plana vitrectomies. He has a
special interest in surgical and medical management of vitreous and retinal
diseases including retinal detachment; diabetic retinopathy; macular diseases
including macular hole and epiretinal membranes; floaters; retinal vein
occlusions; and age-related macular degeneration (including the use of
intravitreal anti-VEGF injections). His surgical expertise also encompasses
simple and complex cataract surgery as well as dealing with complications
of cataract surgery. In addition, he is an expert of complex, sight-
threatening ocular inflammatory disorders (uveitis) especially in the use
of immunosuppressive medications and vitrectomy in dealing with this
condition. He regularly audits his practice to ensure the highest standards of
quality of care.

In addition to his clinical expertise, Mr. Jalil is an integral part of the research
team at Manchester Royal Eye Hospital which has pioneered research into,
amongst others, retinal implants and retinal gene therapy. He is one of the
few retinal surgeons in the world performing retinal gene therapy.

Mr. Jalil has co-authored 3 book chapters in addition to more than 50
publications in peer-reviewed ophthalmic journals. He regularly presents at
national and international meetings. He is the supervisor of the well renowned
Clinical as well as the Research Vitreoretinal fellowships at Manchester Royal
Eye Hospital, and is involved in training surgeons from all over the world.